WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Spreading Traditional Chinese CultureSummer Vacation Campaign of Caring for Children LaunchedShen Yueyue Underlines PeopleACWF to Step up Efforts on Protection of Women and Children's Rights, InterestsWomen Make Their Mark in Archaeological FieldHighlights of shooting at 4th Asian Para GamesACWF Sends Condolences to Family of Nurse Who Lost Her Life in Battle Against COVIDJapan's Sapporo confirms abandoning bid for 2030 Winter OlympicsHelping Ewenki People Escape Poverty by Developing TourismACWF President Calls for Promoting China's COVID
2.7663s , 6500.2265625 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,International Image news portal